• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGS 2.19% $1.40

COGSTATE LTD - News & Media

Cogstate Ltd is a neuroscience technology company. It is engaged in the creation,... Cogstate Ltd is a neuroscience technology company. It is engaged in the creation, validation, and commercialization of digital brain health assessments and design and assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Research. The Clinical Trials segment includes adoption of decentralized clinical trial methodologies and scientific publication and marketing of the utility and validity of Cogstate technology. The Healthcare segment includes Cognigram, which allows for regular and standardized testing to assist in the early detection of cognitive decline that could be related to a range of factors including head injury, neurodegenerative disease or side effects following pharmacological treatments. The Research segment includes research studies and academic collaborations across various indications, such as Alzheimer’s disease and Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No News & Media currently available.

(20min delay)
Last
$1.40
Change
0.030(2.19%)
Mkt cap ! $239.9M
Open High Low Value Volume
$1.38 $1.40 $1.37 $65.27K 46.77K

Buyers (Bids)

No. Vol. Price($)
1 7889 $1.38
 

Sellers (Offers)

Price($) Vol. No.
$1.44 4000 1
View Market Depth
Last trade - 15.50pm 03/05/2024 (20 minute delay) ?
Last
$1.40
  Change
0.030 ( 1.45 %)
Open High Low Volume
$1.39 $1.40 $1.38 930
Last updated 15.20pm 03/05/2024 ?
CGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.